Endometrial Dysbiosis: A Possible Association with Estrobolome Alteration
Biomolecules · 2024
DOI: 10.3390/biom14101325 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Giorgia Scarfò und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Medicine, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy. Hauptthemen laut MEDLINE: Dysbiosis, Endometrium. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Microbiota modification at the endometrial level can favor gynecological diseases and impair women’s fertility. The overgrowth of pathogen microorganisms is related to the contemporary alteration of estrogen-metabolizing bacteria, including β-glucuronidase, thereby enhancing estrogen-related inflammatory states and decreasing anti-inflammatory cells. The possible connection between estrobolome impairment and gynecological diseases has been suggested in animal models. Nevertheless, in humans, coherent evidence on the estrobolome alteration and functionality of the female reproductive tract is still lacking. The objective of this study was to explore alterations in estrogen-related signaling and the putative link with endometrial dysbiosis.
Methods
Women with infertility and repeated implantation failure (RIF, N = 40) were enrolled in order to explore the putative link between estrogen metabolism and endometrial dysbiosis. Endometrial biopsies were used to measure inflammatory and growth factor molecules. β-glucuronidase enzyme activity and estrogen receptor (ER) expression were also assessed.
Results
Herein, increased levels of inflammatory molecules (i.e., IL-1β and HIF-1α) and decreased levels of the growth factor IGF-1 were found in the endometrial biopsies of patients presenting dysbiosis compared to eubiotic ones. β-glucuronidase activity and the expression of ERβ were significantly enhanced in patients in the dysbiosis group. Interestingly, Lactobacilli abundance was inversely related to β-glucuronidase activity and to ERβ expression, thus suggesting that an alteration of the estrogen-activating enzyme may affect the expression of ERs as well.
Conclusions
Overall, these preliminary data suggested a link between endometrial dysbiosis and estrobolome impairment as possible synergistic contributing factors to women infertility and RIF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of General Medicine, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
- Department of Pharmacy, University of Pisa, 56126 Pisa, Italy.
- Division of Gynecology and Obstetrics, Azienda Ospedaliero Universitaria Pisana and Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
- Department of Juridical and Economic Sciences, Pegaso Telematic University, 80143 Napoli, Italy.
- Fanfani, Diagnostics and Health, 50129 Firenze, Italy.
- San Rossore Clinic Care, 56100 Pisa, Italy.
ORCID-Profile: Simona Daniele, Ferdinando Franzoni, Paolo Giovanni Artini
Zitieren
APA
Scarfò, G., Daniele, S., Chelucci, E., Papini, F., Epifani, F., Ruggiero, M., Cela, V., Franzoni, F., & Artini, P. G. (2024). Endometrial Dysbiosis: A Possible Association with Estrobolome Alteration. Biomolecules. https://doi.org/10.3390/biom14101325
Vancouver
Scarfò G, Daniele S, Chelucci E, Papini F, Epifani F, Ruggiero M, et al. Endometrial Dysbiosis: A Possible Association with Estrobolome Alteration. Biomolecules. 2024. doi:10.3390/biom14101325
BibTeX
@article{Scarf2024,
author = {Scarfò, Giorgia and Daniele, Simona and Chelucci, Elisa and Papini, Francesca and Epifani, Francesco and Ruggiero, Maria and Cela, Vito and Franzoni, Ferdinando and Artini, Paolo Giovanni},
title = {Endometrial Dysbiosis: A Possible Association with Estrobolome Alteration},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14101325}
}
EUVIMED